myLaminin News
Canadian Patent Granted for myLaminin Research Data Platform
April 8, 2026
In 2026, myLaminin reached a defining milestone with the granting of its Canadian patent, reinforcing the originality and strength of its core technology.
Built in Canada and serving research and clinical trials teams across North America, myLaminin continues to advance a secure, privacy-first research data management platform designed to meet the needs of modern academic, healthcare, and government environments. This patent recognition further validates our commitment to innovation, compliance, and trusted infrastructure for sensitive research data.
As we continue to grow, this milestone marks an important step in our journey to support researchers with scalable, secure, and ethically governed technology—developed in Canada for the global research community.
myLaminin is a leader in delivering secure, innovative digital solutions designed to meet the challenges of modern governance. Through cutting-edge technology and unwavering commitment to trust and transparency, myLaminin empowers organizations to thrive in the digital age.